SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-052508
Filing Date
2023-10-10
Accepted
2023-10-10 16:04:04
Documents
3
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 12222
2 POA DOCUMENT poa.txt EX-24 3161
3 EX-24.1 DOCUMENT attachment1.txt EX-24.1 3264
  Complete submission text file 0001209191-23-052508.txt   20680
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Issuer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705
Business Address
Park Sangwoo (Reporting) CIK: 0001991118 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40427 | Film No.: 231317947

Mailing Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705
Business Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705 949-396-6830
NKMAX Co., Ltd. (Reporting) CIK: 0001996481 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40427 | Film No.: 231317946